165 related articles for article (PubMed ID: 36928271)
21. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
[TBL] [Abstract][Full Text] [Related]
22. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
Xiang B; Zhang R; Wu X; Zhou X
JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
[TBL] [Abstract][Full Text] [Related]
23. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
[TBL] [Abstract][Full Text] [Related]
24. Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis.
Ishii T; Matsue Y; Matsunaga Y; Iekushi K; Homma Y; Morita Y
Heart Vessels; 2024 Jan; 39(1):25-34. PubMed ID: 37695543
[TBL] [Abstract][Full Text] [Related]
25. Conventional heart failure therapy in cardiac ATTR amyloidosis.
Ioannou A; Massa P; Patel RK; Razvi Y; Porcari A; Rauf MU; Jiang A; Cabras G; Filisetti S; Bolhuis RE; Bandera F; Venneri L; Martinez-Naharro A; Law S; Kotecha T; Virsinskaite R; Knight DS; Emdin M; Petrie A; Lachmann H; Wechelakar A; Petrie M; Hughes A; Freemantle N; Hawkins PN; Whelan C; McMurray JJV; Gillmore JD; Fontana M
Eur Heart J; 2023 Aug; 44(31):2893-2907. PubMed ID: 37216684
[TBL] [Abstract][Full Text] [Related]
26. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
[TBL] [Abstract][Full Text] [Related]
27. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial.
Cox ZL; Zalawadiya SK; Simonato M; Redfors B; Zhou Z; Kotinkaduwa L; Zile MR; Udelson JE; Lim DS; Grayburn PA; Mack MJ; Abraham WT; Stone GW; Lindenfeld J
JACC Heart Fail; 2023 Jul; 11(7):791-805. PubMed ID: 37115135
[TBL] [Abstract][Full Text] [Related]
28. Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study.
Mathews L; Ding N; Sang Y; Loehr LR; Shin JI; Punjabi NM; Bertoni AG; Crews DC; Rosamond WD; Coresh J; Ndumele CE; Matsushita K; Chang PP
J Racial Ethn Health Disparities; 2023 Feb; 10(1):118-129. PubMed ID: 35001343
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.
Smith KV; Dunning JR; Fischer CM; MacLean TE; Bosque-Hamilton JW; Fera LE; Grant JY; Zelle DJ; Matta L; Gaziano TA; MacRae CA; Scirica BM; Desai AS
J Pharm Pract; 2022 Oct; 35(5):747-751. PubMed ID: 33813934
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction.
Zhang X; Sun Y; Zhang Y; Wang N; Sha Q; Yu S; Lv X; Ding Z; Zhang Y; Tse G; Liu Y
ESC Heart Fail; 2023 Apr; 10(2):1035-1042. PubMed ID: 36519802
[TBL] [Abstract][Full Text] [Related]
31. Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction.
Mentz RJ; Lautsch D; Pulungan Z; Kim S; Hilkert R; Teigland C; Yang M; Djatche L
J Card Fail; 2022 Aug; 28(8):1349-1354. PubMed ID: 34930657
[TBL] [Abstract][Full Text] [Related]
32. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
Malgie J; Clephas PRD; Brunner-La Rocca HP; de Boer RA; Brugts JJ
Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917
[TBL] [Abstract][Full Text] [Related]
33. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry.
Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH
J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112
[TBL] [Abstract][Full Text] [Related]
34. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
[TBL] [Abstract][Full Text] [Related]
35. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.
Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH
J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734
[TBL] [Abstract][Full Text] [Related]
36. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
[TBL] [Abstract][Full Text] [Related]
37. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups.
Witting C; Zheng J; Tisdale RL; Shannon E; Kohsaka S; Lewis EF; Heidenreich P; Sandhu A
JACC Heart Fail; 2023 Feb; 11(2):161-172. PubMed ID: 36647925
[TBL] [Abstract][Full Text] [Related]
38. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
[TBL] [Abstract][Full Text] [Related]
39. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
40. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study).
Gupta P; Voors AA; Patel P; Lane D; Anker SD; Cleland JGF; Dickstein K; Filippatos G; Lang CC; van Veldhuisen DJ; Metra M; Zannad F; Samani NJ; Jones DJL; Squire IB; Ng LL
Eur J Heart Fail; 2021 Jul; 23(7):1182-1190. PubMed ID: 33759308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
